{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:14:12Z","timestamp":1779192852354,"version":"3.51.4"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0145272","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T18:48:38Z","timestamp":1450723718000},"page":"e0145272","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents"],"prefix":"10.1371","volume":"10","author":[{"given":"G. Clement","family":"Dobbins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Ugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Yancey","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"ref1","article-title":"Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues","author":"A Koski","year":"2015","journal-title":"Mol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e28694","DOI":"10.4161\/onci.28694","article-title":"Trial Watch:: Oncolytic viruses for cancer therapy","volume":"3","author":"J Pol","year":"2014","journal-title":"Oncoimmunology"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/72628","article-title":"Genomic integration and gene expression by a modified adenoviral vector","volume":"18","author":"C Zheng","year":"2000","journal-title":"Nature biotechnology"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo","volume":"19","author":"J Fueyo","year":"2000","journal-title":"Oncogene"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/mt.2010.161","article-title":"Treatment of cancer patients with a serotype 5\/3 chimeric oncolytic adenovirus expressing GMCSF","volume":"18","author":"A Koski","journal-title":"Mol Ther"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/JVI.70.10.6839-6846.1996","article-title":"Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism","volume":"70","author":"VN Krasnykh","year":"1996","journal-title":"Journal of virology"},{"issue":"1","key":"ref7","first-page":"120","article-title":"A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency","volume":"7","author":"K Suzuki","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"24","key":"ref8","first-page":"5738","article-title":"Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer","volume":"58","author":"CR Miller","year":"1998","journal-title":"Cancer research"},{"issue":"6","key":"ref9","first-page":"1161","article-title":"Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review)","volume":"21","author":"GJ Bauerschmitz","year":"2002","journal-title":"International journal of oncology"},{"issue":"5304","key":"ref10","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"JM Bergelson","year":"1997","journal-title":"Science"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"SJ Russell","year":"2012","journal-title":"Nature biotechnology"},{"issue":"1","key":"ref12","first-page":"275","article-title":"Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells","volume":"8","author":"A Kanerva","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"21","key":"ref13","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-10-0791","article-title":"A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases","volume":"16","author":"KJ Kimball","journal-title":"Clin Cancer Res"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ygyno.2014.01.009","article-title":"Oncolytic vaccinia virotherapy for endometrial cancer","volume":"132","author":"YP Liu","year":"2014","journal-title":"Gynecologic oncology"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"H Wang","journal-title":"Nat Med"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp100219n","article-title":"Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data","volume":"8","author":"S Pesonen","year":"2011","journal-title":"Molecular pharmaceutics"},{"issue":"5566","key":"ref17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"P Matzinger","year":"2002","journal-title":"Science"},{"issue":"34","key":"ref18","doi-asserted-by":"crossref","first-page":"12550","DOI":"10.1073\/pnas.1405839111","article-title":"MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma","volume":"111","author":"BJ Gill","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"C Heise","year":"2000","journal-title":"Nat Med"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/JVI.70.7.4805-4810.1996","article-title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli","volume":"70","author":"C Chartier","year":"1996","journal-title":"Journal of virology"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jmb.2006.11.090","article-title":"Thermostability\/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor","volume":"366","author":"H Ugai","year":"2007","journal-title":"J Mol Biol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bbrc.2005.03.227","article-title":"Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration","volume":"331","author":"H Ugai","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"ref23","first-page":"115","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"JV Maizel Jr.","year":"1968","journal-title":"Virology"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005072-198105000-00001","article-title":"Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas","volume":"40","author":"DD Bigner","year":"1981","journal-title":"Journal of neuropathology and experimental neurology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jmb.2009.10.034","article-title":"In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection","volume":"395","author":"H Ugai","journal-title":"J Mol Biol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3171\/JNS-07\/09\/0617","article-title":"Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells","volume":"107","author":"IV Ulasov","year":"2007","journal-title":"J Neurosurg"},{"issue":"15","key":"ref27","first-page":"4434","article-title":"E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer","volume":"63","author":"K Fukuda","year":"2003","journal-title":"Cancer research"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ymthe.2004.07.014","article-title":"Impact of E1a modifications on tumor-selective adenoviral replication and toxicity","volume":"10","author":"H Sauthoff","year":"2004","journal-title":"Mol Ther"},{"issue":"7310","key":"ref29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nature09307","article-title":"Heterochromatin silencing of p53 target genes by a small viral protein","volume":"466","author":"C Soria","year":"2010","journal-title":"Nature"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1073\/pnas.040557897","article-title":"Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors","volume":"97","author":"JN Parker","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"e86843","DOI":"10.1371\/journal.pone.0086843","article-title":"Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors","volume":"9","author":"ML Megison","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"L Lenaerts","year":"2008","journal-title":"Reviews in medical virology"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ymthe.2004.01.012","article-title":"Use of adenovirus protein IX (pIX) to display large polypeptides on the virion\u2014generation of fluorescent virus through the incorporation of pIX-GFP","volume":"9","author":"RA Meulenbroek","year":"2004","journal-title":"Mol Ther"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2310\/7290.2009.00025","article-title":"Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer","volume":"8","author":"KJ Kimball","year":"2009","journal-title":"Molecular imaging"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.02032-10","article-title":"Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity","volume":"85","author":"H Jiang","journal-title":"Journal of virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.ge.20.120186.000401","article-title":"Adenovirus promoters and E1A transactivation","volume":"20","author":"AJ Berk","year":"1986","journal-title":"Annual review of genetics"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1128\/JVI.70.4.2296-2306.1996","article-title":"The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells","volume":"70","author":"AE Tollefson","year":"1996","journal-title":"Journal of virology"},{"issue":"Suppl 1","key":"ref38","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1002\/jgm.495","article-title":"Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins","volume":"6","author":"MS Horwitz","year":"2004","journal-title":"J Gene Med"},{"issue":"34","key":"ref39","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1200\/JCO.2009.24.3675","article-title":"Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma","volume":"27","author":"NN Senzer","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref40","first-page":"13","article-title":"Clinical uses of GM-CSF, a critical appraisal and update","volume":"2","author":"M Arellano","year":"2008","journal-title":"Biologics"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/hum.2010.180","article-title":"A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5\/3-Delta24 in advance of a phase I clinical trial in ovarian cancer patients","volume":"22","author":"KH Kim","journal-title":"Hum Gene Ther"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/1535-7163.MCT-06-0187","article-title":"Enhanced transduction of malignant glioma with a double targeted Ad5\/3-RGD fiber-modified adenovirus","volume":"5","author":"MA Tyler","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4161\/cbt.2.5.440","article-title":"Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5\/3 chimerism","volume":"2","author":"AL Volk","year":"2003","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"ref44","first-page":"1213","article-title":"Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck","volume":"31","author":"ZB Zhu","year":"2007","journal-title":"International journal of oncology"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/14796694.2.1.137","article-title":"Current developments in adenovirus-based cancer gene therapy","volume":"2","author":"DT Rein","year":"2006","journal-title":"Future Oncol"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1128\/JVI.72.3.2055-2061.1998","article-title":"Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase","volume":"72","author":"E Li","year":"1998","journal-title":"Journal of virology"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"e1003718","DOI":"10.1371\/journal.ppat.1003718","article-title":"Penton-dodecahedral particles trigger opening of intercellular junctions and facilitate viral spread during adenovirus serotype 3 infection of epithelial cells","volume":"9","author":"ZZ Lu","year":"2013","journal-title":"PLoS pathogens"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/mt.2012.116","article-title":"Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo","volume":"20","author":"AM Young","year":"2012","journal-title":"Mol Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0145272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T02:02:26Z","timestamp":1599962546000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0145272"}},"subtitle":[],"editor":[{"given":"Kensuke","family":"Hirasawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0145272","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}